The Future of Drug Pricing

Could global pressure on health spending force the pharmaceutical industry to embrace pricing drugs based on clinical outcomes instead of how many pills or vials are sold? Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.